ARCHIVES

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

This article is from The Cancer Letter archive.

Vol. 30 No. 41 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

$5 Million Lift Raises Payline From 180 to 185

May 21, 1982

CCOP 2 Under Way After Bitter Recompetition Cancer Control Protocols Being Review; PLs, Affiliates Listed

February 19, 1988

Chart of Core Grants

October 18, 1991

In Brief: Schwarzkopf In NCCS TV Spot; AACI elects Officers; Nobel Prize In Medicine awarded

October 18, 1996

NCI funds biorepository for prostate cancer SPOREs.

November 11, 2005

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013